Andrew Dudum - 21 Jan 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
21 Jan 2025
Net transactions value
-$402,782
Form type
4
Filing time
23 Jan 2025, 16:32:18 UTC
Previous filing
23 Jan 2025
Next filing
24 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $729 +300 +1.1% $2.43 28,218 21 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Sale $9,000 -300 -1.1% $30.00 27,918 21 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Options Exercise $34,674 +14,269 +51% $2.43 42,187 22 Jan 2025 Direct F1
transaction HIMS Class A Common Stock Sale $429,184 -14,269 -34% $30.08 27,918 22 Jan 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -300 -0.02% $0.000000 1,547,768 21 Jan 2025 Class A Common Stock 300 $2.43 Direct F1, F3
transaction HIMS Stock Option (right to buy) Options Exercise $0 -14,269 -0.92% $0.000000 1,533,499 22 Jan 2025 Class A Common Stock 14,269 $2.43 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $30.00 - $30.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.